Neurology News

Edgewise Therapeutics Inc. announced positive 4-month interim results from the ongoing ARCH study of investigational, orally administered EDG-5506 for the treatment of Becker muscular dystrophy in adults.

Between the loss of income and increases in medical care costs, disabling injuries suffered by high-income physicians can cause financial devastation that far exceeds that of their premature death.

Low-dose ketamine was generally safe, well-tolerated and effective in treating clinical symptoms in a small group of children with activity-dependent neuroprotective protein syndrome, researchers reported.

Researchers at the University of Kentucky’s Sanders-Brown Center on Aging have received a $20.5 million grant from the National Institute on Aging to study astrocytes and their role in Alzheimer’s disease and other forms of dementia.

An Alzheimer's disease-centered storyline in the primetime television drama series “This Is Us” reduced stigma around dementia and prompted family discussions, researchers reported in the Journal of Health Communications.

Older adults with dementia are at greater risk for SARS-CoV-2 infection and death, highlighting the need for close monitoring of these patients, researchers reported in the Journal for Alzheimer’s Disease.

The FDA has granted breakthrough device designation to Magnus Medical for its neuromodulation treatment of major depressive disorder in adults who failed to achieve improvement from previously prescribed antidepressants.

LAS VEGAS — Results from a nationally representative survey of U.S. adults indicated strong use of various self-care options, with over-the-counter pain relievers the most common, according to a poster presented at PAINWeek 2022.

Anthos Therapeutics announced abelacimab, a fully human monoclonal antibody inhibiting factor XI, received fast track designation from the FDA for an indication to prevent stroke and systemic embolism in patients with atrial fibrillation.

The FDA in August issued a final rule to establish a new category of over-the-counter hearing aids, which will enable consumers with perceived mild to moderate hearing impairment to purchase hearing aids directly from stores or online retailers.